Story

What this case means
This case challenged the absence of an enforceable legal framework to regulate unethical marketing by pharmaceutical companies to doctors. The Supreme Court directed the Union of India to constitute a committee within two weeks to examine the regulatory framework and recommend statutory or regulatory changes. The judgment reinforces that the right to health under Article 21 demands effective, transparent, and accountable pharmaceutical marketing regulation.
What the Supreme Court held
The Supreme Court, exercising jurisdiction under Articles 32 and 142 of the Constitution, directed the Union of India to constitute the proposed three-member Committee within two weeks. The Committee must consult petitioners, intervenors and other stakeholders, may seek expert assistance, and is required to submit its recommendations to the Union of India within two months of its first meeting. The Union of India must then take a reasoned decision and file a compliance affidavit; the matter is listed for 29 January 2027.
Case: Federation of Medical & Sales Representatives Association of India & Ors. vs Union of India & Ors. (2026) Citation: 2026 INSC 1097
Want the full legal reasoning, citations and case documents?
Read the full judgment analysis